The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Drazer, Michael
One or more keywords matched the following properties of Drazer, Michael
PropertyValue
keywords Genomics
keywords Cancers
overview Dr. Drazer's laboratory research focuses on determining the mechanisms that drive hereditary blood and cancer syndromes, with a particular emphasis on developing "high fidelity" cellular and mouse models of these disorders. He is also involved in the discovery of novel hereditary blood and cancer syndromes. His clinical research is largely focused on optimizing the care of people with hereditary blood and cancer syndromes, including the development of clinical bioinformatics pipelines that improve the diagnosis of patients with these syndromes. He is a member of multiple clinical disease groups at the University of Chicago.
One or more keywords matched the following items that are connected to Drazer, Michael
Item TypeName
Concept Breast Neoplasms
Concept Lung Neoplasms
Concept Prostatic Neoplasms
Concept Testicular Neoplasms
Concept Neoplasms, Second Primary
Concept Peritoneal Neoplasms
Concept Early Detection of Cancer
Concept Hematologic Neoplasms
Concept Neoplasms
Academic Article Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States.
Academic Article Global trends in testicular cancer incidence and mortality.
Academic Article 2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.
Academic Article National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
Academic Article National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.
Academic Article Analysis of Impact of Post-Treatment Biopsies in Phase I Clinical Trials.
Academic Article Patient-Initiated Prostate Cancer Screening Among Older U.S. Men.
Academic Article Stereotactic body radiotherapy for oligometastatic breast cancer: a new standard of care, or a medical reversal in waiting?
Academic Article The Role of Testosterone in the Treatment of Castration-Resistant Prostate Cancer.
Academic Article Genetic predisposition to leukemia and other hematologic malignancies.
Academic Article Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies.
Academic Article Low clinical adoption of tumor genomic profiling: cause for concern?
Academic Article Assessment of technical heterogeneity among diagnostic tests to detect germline risk variants for hematopoietic malignancies.
Academic Article Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes.
Academic Article Germline predisposition to hematopoietic malignancies.
Academic Article The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy.
Academic Article Therapy-related myeloid neoplasms in 109 patients after radiation monotherapy.
Academic Article Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision Oncology.
Academic Article Stagnation in quality of next-generation sequencing assays for the diagnosis of hereditary hematopoietic malignancies.
Concept Prostatic Neoplasms, Castration-Resistant
Academic Article Surgical phenotype of patients with peritoneal mesothelioma and a germline mutation.
Academic Article Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.
Academic Article Clinical guideline variability in the diagnosis of hereditary hematopoietic malignancy syndromes.
Academic Article Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma.
Academic Article Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy.
Search Criteria
  • Cancer
  • Genomics